28-Aug-2026
Globe Newswire (Thu, 27-Aug 10:15 AM ET)
Inspire Medical Systems, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference
Globe Newswire (Wed, 26-Aug 9:15 AM ET)
Addition of Dr. Myriam Curet to Mobia Medical Board Highlights Surge in Clinical Leadership
Market Chameleon (Tue, 4-Aug 4:04 AM ET)
Mobia Medical Appoints Myriam Curet, M.D., to its Board of Directors
Globe Newswire (Mon, 3-Aug 4:05 PM ET)
Globe Newswire (Mon, 3-Aug 4:02 PM ET)
Globe Newswire (Mon, 27-Jul 8:00 AM ET)
Business Wire (Fri, 24-Jul 5:55 PM ET)
Inspire Medical Systems, Inc. Announces Retirement of Casey M. Tansey from its Board of Directors
Globe Newswire (Wed, 22-Jul 8:00 AM ET)
Globe Newswire (Mon, 6-Jul 9:48 AM ET)
Inspire Medical Systems, Inc. to Report Second Quarter 2026 Financial Results on July 6, 2026
Globe Newswire (Mon, 6-Jul 8:00 AM ET)
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.
Inspire Medical Systems trades on the NYSE stock market under the symbol INSP.
As of August 28, 2026, INSP stock price climbed to $61.44 with 295,050 million shares trading.
INSP has a beta of 1.53, meaning it tends to be more sensitive to market movements. INSP has a correlation of 0.07 to the broad based SPY ETF.
INSP has a market cap of $1.77 billion. This is considered a Small Cap stock.
Last quarter Inspire Medical Systems reported $201 million in Revenue and $.14 earnings per share. This beat revenue expectation by $6 million and exceeded earnings estimates by $.38.
In the last 3 years, INSP traded as high as $257.40 and as low as $38.91.
The top ETF exchange traded funds that INSP belongs to (by Net Assets): IJR, IWM, VTI, VB, VBK.
INSP has underperformed the market in the last year with a return of -32.8%, while SPY returned +19.7%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in INSP shares. However, INSP has outperformed the market in the last 3 month and 2 week periods, returning +42.7% and +7.6%, while SPY returned +2.2% and -0.9%, respectively. This indicates INSP has been having a stronger performance recently.
INSP support price is $58.66 and resistance is $62.98 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that INSP shares will trade within this expected range on the day.